Study aims to find best way to shield kids from painful procedure complication
NCT ID NCT05664074
Summary
This study aimed to find the best way to prevent a painful pancreas inflammation (pancreatitis) that can happen after a common medical procedure called ERCP in children. Researchers compared two widely used anti-inflammatory drugs, one given as a rectal suppository (indomethacin) and one given through an IV (ketorolac). The goal was to see which medication was more effective at reducing the rate of this complication in 192 young patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-ERCP ACUTE PANCREATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
Conditions
Explore the condition pages connected to this study.